In this study, we aimed at analyzing the association of intratumoral and peritumoral TAM using a pan-macrophage marker CD68+ and their pro-tumor CD163+ subset, as well as CD117+ mast cells, individually and in pairs, with outcomes and clinicopathological characteristics of European patients after curative resection of HCC. The gene discussed is CD163; the disease is hepatocellular carcinoma.